Suppr超能文献

相似文献

1
Specific inhibition of PI3K p110δ inhibits CSF-1-induced macrophage spreading and invasive capacity.
FEBS J. 2013 Nov;280(21):5228-36. doi: 10.1111/febs.12316. Epub 2013 Jun 5.
3
Distinct roles of class IA PI3K isoforms in primary and immortalised macrophages.
J Cell Sci. 2008 Dec 15;121(Pt 24):4124-33. doi: 10.1242/jcs.032763. Epub 2008 Nov 25.
4
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
Blood. 2010 Sep 2;116(9):1460-8. doi: 10.1182/blood-2009-06-222943. Epub 2010 May 26.
6
Functional CSF-1 receptors are located at the nuclear envelope and activated via the p110δ isoform of PI 3-kinase.
FASEB J. 2012 Feb;26(2):691-706. doi: 10.1096/fj.11-189753. Epub 2011 Nov 11.
8
CSF-1 receptor signalling is governed by pre-requisite EHD1 mediated receptor display on the macrophage cell surface.
Cell Signal. 2016 Sep;28(9):1325-1335. doi: 10.1016/j.cellsig.2016.05.013. Epub 2016 May 17.

引用本文的文献

1
The role of macrophage migratory behavior in development, homeostasis and tumor invasion.
Front Immunol. 2024 Nov 11;15:1480084. doi: 10.3389/fimmu.2024.1480084. eCollection 2024.
2
Focus on Pancreatic Cancer Microenvironment.
Curr Oncol. 2024 Jul 26;31(8):4241-4260. doi: 10.3390/curroncol31080316.
3
Mechanisms of Altered Immune Response in Skin Melanoma.
Curr Health Sci J. 2023 Jul-Sep;49(3):297-311. doi: 10.12865/CHSJ.49.03.01. Epub 2023 Sep 30.
4
PI3K Isoform Immunotherapy for Solid Tumours.
Curr Top Microbiol Immunol. 2022;436:369-392. doi: 10.1007/978-3-031-06566-8_16.
5
Dual PI3Kδ/γ Inhibitor Duvelisib Prevents Development of Neuropathic Pain in Model of Paclitaxel-Induced Peripheral Neuropathy.
J Neurosci. 2022 Mar 2;42(9):1864-1881. doi: 10.1523/JNEUROSCI.1324-21.2021. Epub 2022 Jan 18.
6
A proteogenomic portrait of lung squamous cell carcinoma.
Cell. 2021 Aug 5;184(16):4348-4371.e40. doi: 10.1016/j.cell.2021.07.016.
7
Inflammation and tumor progression: signaling pathways and targeted intervention.
Signal Transduct Target Ther. 2021 Jul 12;6(1):263. doi: 10.1038/s41392-021-00658-5.
8
Overcoming Immune Evasion in Melanoma.
Int J Mol Sci. 2020 Nov 26;21(23):8984. doi: 10.3390/ijms21238984.
9
Autoimmune Complications in Chronic Lymphocytic Leukemia in the Era of Targeted Drugs.
Cancers (Basel). 2020 Jan 23;12(2):282. doi: 10.3390/cancers12020282.
10
A three-dimensional co-culture system to investigate macrophage-dependent tumor cell invasion.
J Biol Methods. 2016 Jul 24;3(3):e49. doi: 10.14440/jbm.2016.132. eCollection 2016.

本文引用的文献

1
Targeting the microenvironment in chronic lymphocytic leukemia is changing the therapeutic landscape.
Curr Opin Oncol. 2012 Nov;24(6):643-9. doi: 10.1097/CCO.0b013e3283589950.
2
Decreased mitochondrial apoptotic priming underlies stroma-mediated treatment resistance in chronic lymphocytic leukemia.
Blood. 2012 Oct 25;120(17):3501-9. doi: 10.1182/blood-2012-02-414060. Epub 2012 Sep 5.
3
Macrophage Migration and Its Regulation by CSF-1.
Int J Cell Biol. 2012;2012:501962. doi: 10.1155/2012/501962. Epub 2012 Feb 15.
4
CSF-1 signaling in macrophages: pleiotrophy through phosphotyrosine-based signaling pathways.
Crit Rev Clin Lab Sci. 2012 Mar-Apr;49(2):49-61. doi: 10.3109/10408363.2012.666845.
10
PI3K/p110{delta} is a novel therapeutic target in multiple myeloma.
Blood. 2010 Sep 2;116(9):1460-8. doi: 10.1182/blood-2009-06-222943. Epub 2010 May 26.

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验